For years, studies have suggested cannabinoids fight different forms of breast cancer. THC has been shown to induce apoptosis in ErbB2-positive breast cancer cells and inhibit tumor growth in animals. CBD is known to work at the genetic level, blocking expression of the ID-1 gene to inhibit breast cancer metastasis.
A January 2015 study in Molecular Oncology extensively detailed the numerous ways CBD fights triple-negative breast cancer. By inhibiting epidermal growth factor (EGF) and its related receptor, CBD reduced the proliferation, migration, and invasion of TNBC cells. It also lowered the amount of inflammatory cytokines released by cancer cells, along with two matrix metalloproteinase enzymes associated with metastasis. Through these effects, CBD inhibited breast cancer growth and metastasis in two mouse models.
Given these studies, it is no surprise that many humans have had direct success against their cancers with cannabis extracts. Read more